The indication of proton therapy in the treatment of prostate cancer from the PTC is part of the recommendation “list of indications for proton therapy” as elaborated by the PTC expert committee (including radiation oncologists and other specialists). It is based on common indications in proton centers throughout the world and recommended by professional organizations dealing with proton radiotherapy (PTCOG, NAPT).

The Position of Proton Radiotherapy of Prostate Cancer in the World:

Proton radiotherapy is a common method in the proton centres all around the world. American Society for Radiation Oncology (ASTRO) supported the use of the proton radiotherapy in the treatment of prostate cancer within clinical trials or registries in 2013 (https://www.astro.org/News-and-Media/News-Releases/2013/ASTRO-Board-of-Directors-approves-statement-on-use-of-proton-beam-therapy-for-prostate-cancer.aspx).

In its model, the same ASTRO committee recommended proton therapy reimbursement from health insurance in 2014 (https://www.astro.org/uploadedFiles/Main_Site/Practice_Management/Reimbursement/ASTRO%20PBT%20Model%20Policy%20FINAL.pdf).

In 2017, the ASTRO committee updated its recommendations to healthcare providers and explicitly listed non-metastatic prostate cancer as an indication eligible for reimbursement under the terms of clinical trials or prospective registries (https://www.astro.org/News-and-Publications/News-and-Media-Center/News-Releases/2017/ASTRO-updates-insurance-coverage-recommendations-for-proton-therapy/).

In 2018, proton radiotherapy for prostate cancer was included in the National Comprehensive Cancer Network (NCCN) guidelines and is therefore recognized as standard treatment. These recommendations are respected and accepted worldwide by national oncology societies, so proton radiotherapy for prostate cancer can be described as a completely standard and appropriate treatment.

Proton radiotherapy for prostate cancer is performed in all proton centers around the world. All centers, some of which are the leaders of the world of oncology, include this diagnosis in their basic indications. See, for example:

MD Anderson Cancer Centerhttp://www.mdanderson.org/patient-and-cancer-information/proton-therapy-center/conditions-we-treat/prostate-cancer/index.html

MGH Bostonhttp://www.massgeneral.org/radiationoncology/research/researchlab.aspx?id=1630

UPENNhttp://www.pennprotontherapy.org/cancers-we-treat/

University of Floridahttp://www.floridaproton.org/cancers-treated/prostate-cancer

Scripps proton therapy center, San Diegohttp://www.scripps.org/services/cancer-care__proton-therapy/conditions-treated__proton-therapy-for-prostate-cancer

Loma Linda Proton therapy center, Californiahttp://www.protons.com/proton-therapy/proton-treatments/prostate-cancer/about-the-prostate.page

University of Floridahttp://www.floridaproton.org/cancers-treated/prostate-cancer

Book "Protonová radioterapie", author Pavel Vítek et al., published by Maxdorf

Purchase the book via the link below.

Book "Co byste měli vědět o rakovině prsu", author Jitka Abrahámová et al., published by Grada

Purchase the book via the link below.